149 Fifth Avenue
Suite 500
New York, NY 10010
United States
212 994 8200
https://www.protagenic.com
Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 1
Name | Title | Pay | Exercised | Year born |
---|---|---|---|---|
Dr. Garo H. Armen Ph.D. | Co-Founder & Executive Chairman of the Board | N/A | N/A | 1953 |
Dr. Alexander Kenneth Arrow C.F.A., M.D. | CFO & Secretary | 150k | N/A | 1971 |
Dr. Andrew Slee Ph.D. | Chief Operating Officer | N/A | N/A | 1950 |
Dr. Robert Benjamin Stein M.D., Ph.D. | Chief Medical Officer & Director | N/A | N/A | 1951 |
Protagenic Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. The company's lead compound comprises PT00114, a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. Protagenic Therapeutics, Inc. is headquartered in New York, New York.
Protagenic Therapeutics, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.